QIAstat-Dx胃肠道面板诊断感染性胃肠炎的性能评估
本研究以172份疑似感染性胃肠炎患者粪便样本,比较QIAstat-Dx胃肠道面板(GIP)与实验室自建实时PCR(LDT)的检测性能。GIP检出LDT所检107种病原体中的97种(91%),排除CT值>35的不一致结果后总体一致性升至95%,并额外检出42种LDT未检或未测病原体。
要点
- GIP对LDT检出病原体的符合率为91%,排除CT>35不一致后升至95%。
- GIP额外检出42种病原体,含35种临床相关性不明的致泻性大肠埃希菌。
- GIP可报告CT值,有助于结果解释,但灵活性和高通量不及LDT。
核心结论
- GIP提供样本进结果出的快速流程,可检测最常见肠道病原体,有望指导治疗和感染控制。
研究设计与样本
- 研究纳入172份前瞻性和回顾性收集的疑似感染性胃肠炎患者粪便样本,比较GIP与LDT的检测性能。
主要发现
- GIP检出LDT所检107种病原体中的97种(91%)。
- 排除CT值>35的不一致结果后,总体一致性升至95%。
- GIP额外检出42种LDT未检出或未检测的病原体,包括35种致泻性大肠埃希菌靶标。
关键数值与推荐
- GIP可同时检测24种细菌、病毒和寄生虫肠道病原体,70分钟报告结果。
临床怎么用
- GIP快速样本进结果出流程可用于指导适当治疗和感染控制措施。
- GIP报告的CT值可辅助结果解释。
局限性
- 与LDT相比,GIP在灵活性和高通量检测方面受限。
- 额外检出的35种致泻性大肠埃希菌靶标多数临床相关性不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Detection and identification of enteropathogens that cause infectious gastroenteritis are essential steps for appropriate patient treatment and effective isolation precautions. Several syndrome-based tests have recently become available, with the gastrointestinal panel (GIP) assay on the QIAstat-Dx as the most recent addition to the syndromic testing landscape. The QIAstat-Dx GIP assay offers simultaneous testing for 24 bacterial, viral, and parasitic enteropathogens using a single test that reports the results in 70 min. In this study, we compared the performance of the GIP assay to laboratory-developed real-time PCR assays (LDTs), using 172 prospectively and retrospectively collected fecal samples from patients suspected to have infectious gastroenteritis. The GIP assay detected 97/107 enteropathogens (91%) that were detected by LDTs, and the overall agreement of results increased to 95% when excluding discrepant results with cycle threshold (CT ) values of >35. Further, the GIP assay detected 42 additional enteropathogens that were not detected, or tested, by LDTs. These included 35 diarrheagenic Escherichia coli targets for which the clinical relevance is unclear for most. The main advantage of the QIAstat-Dx system compared to other syndromic testing systems is the ability to generate CT values that could help with the interpretation of results. However, compared to LDTs, the GIP assay is limited by flexibility and high-throughput testing. In conclusion, the GIP assay offers an easy, sample-to-answer workflow with a rapid detection of the most common enteropathogens and therefore has the potential to direct appropriate therapy and infection control precautions.
引用
- Boers SA, Peters CJA, Wessels E, et al. Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis. J Clin Microbiol. 2020. PMID: 31915286. doi:10.1128/JCM.01737-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。